Clinical outcomes and response of patients applying topical therapy for pyoderma gangrenosum: A prospective cohort study
Open Access
- 5 August 2016
- journal article
- Published by Elsevier BV in Journal of the American Academy of Dermatology
- Vol. 75 (5), 940-949
- https://doi.org/10.1016/j.jaad.2016.06.016
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Topical tacrolimus 0.1% ointment for treatment of cutaneous Crohn’s DiseaseBMC Research Notes, 2013
- Recruitment into trials of rare conditions - experiences from the STOP GAP trialTrials, 2011
- Pyoderma gangrenosum: a retrospective review of patient characteristics, comorbidities and therapy in 103 patientsBritish Journal of Dermatology, 2011
- Pyoderma gangrenosum: Study of 21 patients and proposal of a ‘clinicotherapeutic’ classificationJournal of Dermatological Treatment, 2010
- A review of health utilities using the EQ-5D in studies of cardiovascular diseaseHealth and Quality of Life Outcomes, 2010
- A Comparison of Two Regimens of Topical Corticosteroids in the Treatment of Patients with Bullous Pemphigoid: A Multicenter Randomized StudyJournal of Investigative Dermatology, 2009
- An open-label pilot study of alefacept for the treatment of pyoderma gangrenosumJournal of the European Academy of Dermatology and Venereology, 2008
- Diagnosis and treatment of pyoderma gangrenosumBMJ, 2006
- Topical tacrolimus in the management of peristomal pyoderma gangrenosumJournal of Dermatological Treatment, 2001
- Dermatology Life Quality Index (DLQI)-a simple practical measure for routine clinical useClinical and Experimental Dermatology, 1994